Gene editing moved quickly from the lab to application, so fast that the public is unsure how to think about it.  We can cure disease, but are we playing with the natural order of things? These are questions that philosophers and ethicists wrestle with every day.  in this week’s podcast we discuss the recent events in germline gene editing and how it is perceived by the public and by scientists.Follow Dr. Gyngell’s group:  @Berg_MCRI# COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.